Women's perception of risks of adverse fetal pregnancy outcomes: A large-scale multinational survey

BMJ Open

Volumn 5, Issue 6, 2015, Pages

  Petersen, Irene ^a   McCrea, Rachel L ^a   Lupattelli, Angela ^b   Nordeng, Hedvig ^b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; NON PRESCRIPTION DRUG; PRESCRIPTION DRUG; THALIDOMIDE;

ADOLESCENT; ADULT; ARTICLE; ASSESSMENT OF HUMANS; AUSTRALIA; CONGENITAL MALFORMATION; CONTROLLED STUDY; CRANBERRY; EDUCATION; EUROPE; FEMALE; FETUS OUTCOME; FOOD; GINGER; HUMAN; LARGE SCALE PRODUCTION; MAJOR CLINICAL STUDY; NORTH AMERICA; OCCUPATION; PERCEPTION; PREGNANCY OUTCOME; PREGNANT WOMAN; PRESCRIPTION; RISK PERCEPTION SCORE; SMOKING; TOBACCO; ADVERSE EFFECTS; AGE; ATTITUDE TO HEALTH; CLINICAL TRIAL; CONGENITAL ABNORMALITIES; DRINKING BEHAVIOR; EDUCATIONAL STATUS; MIDDLE AGED; MOTHER; MULTICENTER STUDY; PREGNANCY; PSYCHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; ALCOHOL DRINKING; ATTITUDE TO HEALTH; AUSTRALIA; CONGENITAL ABNORMALITIES; EDUCATIONAL STATUS; EUROPE; FEMALE; FOOD; HUMANS; MIDDLE AGED; MOTHERS; NONPRESCRIPTION DRUGS; NORTH AMERICA; PERCEPTION; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMEN; SMOKING; YOUNG ADULT;

EID: 84931274681     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-007390     Document Type: Article

References (41)

1. McBride W. Thalidomide and congenital abnormalities. Lancet 1961; 2: 1358.
2. Petersen I, Gilbert RE, Evans SJW, et al. Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network. J Clin Psychiatry 2011; 72: 979-85.
3. Man SL, Petersen I, Thompson M, et al. Antiepileptic drugs during pregnancy in primary care: a UK population based study. PLoS ONE 2012; 7: e52339.
4. Nordeng H, Ystrom E, Einarson A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol 2010; 66: 207-14.
5. Lupattelli A, Spigset O, Nordeng H. Adherence to medication for chronic disorders during pregnancy: results from a multinational study. Int J Clin Pharm 2014; 36: 145-53.
6. Sanz E, Gómez-López T, Martínez-Quintas MJ. Perception of teratogenic risk of common medicines. Eur J Obstet Gynecol Reprod Biol 2001; 95: 127-31.
7. Petersen I, McCrea RL, Osborn DJP, et al. Discontinuation of antipsychotic medication in pregnancy: a cohort study. Schizophr Res 2014; 159: 218-25.
8. Larsson M. A descriptive study of the use of the Internet by women seeking pregnancy-related information. Midwifery 2009; 25: 14-20.
9. Nordeng H, Koren G, Einarson A. Pregnant women's beliefs about medications-a study among 866 norwegian women. Ann Pharmacother 2010; 44: 1478-84.
10. Koren G, Bologa M, Long D, et al. Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester. Am J Obstet Gynecol 1989; 160(5 Pt 1): 1190-4.
11. Heaman M, Gupton A, Gregory D. Factors influencing pregnant women's perceptions of risk. MCN Am J Matern Child Nurs 2004; 29: 111-16.
12. Bayrampour H, Heaman M, Duncan KA, et al. Comparison of perception of pregnancy risk of nulliparous women of advanced maternal age and younger age. J Midwifery Womens Health 2012; 57: 445-53.
13. Bayrampour H, Heaman M, Duncan KA, et al. Predictors of perception of pregnancy risk among nulliparous women. J Obstet Gynecol Neonatal Nurs 2013; 42: 416-27.
14. Gupton A, Heaman M, Cheung LW. Complicated and uncomplicated pregnancies: women's perception of risk. J Obstet Gynecol Neonatal Nurs 2001; 30: 192-201.
15. Sijtsma K, Molenaar IW. Introduction to nonparametric item response theory. Thousand Oaks, California: Sage Publications, 2002.
16. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria, 2012. http://www.R-project.org/
17. Van der Ark LA. Mokken scale analysis in R. J Stat Softw 2007; 20: 1-19.
18. Revelle W. Psych: procedures for psychological, psychometric, and personality research. Evanston, Illinois: Northwestern University, 2013. http://CRAN.R-project.org/package=psych
19. Labeling > Summary of Proposed Rule on Pregnancy and Lactation Labeling. (cited 22 Jun 2014). http://www.fda.gov/drugs/developmentapprovalprocess/developmentresources/labeling/ucm093310.htm
20. Lupattelli A, Spigset O, Twigg MJ, et al. Medication use in pregnancy: a cross-sectional, multinational web-based study. BMJ Open 2014; 4: e004365.
21. Kennedy DA, Lupattelli A, Koren G, et al. Herbal medicine use in pregnancy: results of a multinational study. BMC Complement Altern Med 2013; 13: 355.
22. Pedersen LH, Henriksen TB, Vestergaard M, et al. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. Br Med J 2009; 339: b3569.
23. Malm H, Artama M, Gissler M, et al. Selective serotonin reuptake inhibitors and risk for major congenital anomalies. Obstet Gynecol 2011; 118: 111-20.
24. Ban L, Gibson J, West J, et al. Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study. BJOG 2014; 121: 1471-81.
25. Grigoriadis S, VonderPorten EH, Mamisashvili L, et al. The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis. J Clin Psychiatry 2013; 74: e309-20.
26. Wurst KE, Poole C, Ephross SA, et al. First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies. Birth Defects Res A Clin Mol Teratol 2010; 88: 159-70.
27. Huybrechts KF, Palmsten K, Avorn J, et al. Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med 2014; 370: 2397-407.
28. Hämeen-Anttila K, Nordeng H, Kokki E, et al. Multiple information sources and consequences of conflicting information about medicine use during pregnancy: a multinational internet-based survey. J Med Internet Res 2014; 16: e60.
29. Foods to avoid during pregnancy-Health questions-NHS Choices (cited 16 June 2014). http://www.nhs.uk/chq/Pages/917.aspx?CategoryID=54#close
30. Holst L, Wright D, Nordeng H, et al. Use of herbal preparations during pregnancy: focus group discussion among expectant mothers attending a hospital antenatal clinic in Norwich, UK. Complement Ther Clin Pract 2009; 15: 225-9.
31. Peadon E, Payne J, Henley N, et al. Women's knowledge and attitudes regarding alcohol consumption in pregnancy: a national survey. BMC Public Health 2010; 10: 510.
32. Raymond N, Beer C, Glazebrook C, et al Pregnant women's attitudes towards alcohol consumption. BMC Public Health 2009; 9: 175.
33. Ekman A, Dickman PW, Klint A, et al. Feasibility of Using Web-based Questionnaires in large population-based epidemiological studies. Eur J Epidemiol 2006; 21: 103-11.
34. Millar LK, Cox SM. Urinary tract infections complicating pregnancy. Infect Dis Clin North Am 1997; 11: 13-26.
35. O'hara MW, Swain AM. Rates and risk of postpartum depression-a meta-analysis. Int Rev Psychiatry 1996; 8: 37-54.
36. Grote NK, Bridge JA, Gavin AR, et al. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry 2010; 67: 1012-24.
37. Einarson A, Choi J, Einarson TR, et al. Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database. J Obstet Gynaecol Can 2009; 31: 452-6.
38. Walfisch A, Sermer C, Matok I, et al. Perception of teratogenic risk and the rated likelihood of pregnancy termination: association with maternal depression. Can J Psychiatry Rev Can Psychiatr 2011; 56: 761-7.
39. The Hospital for Sick Children-Motherisk-Drugs in Pregnancy (cited 5 July 2014). http://www.motherisk.org/women/drugs.jsp
40. UKTIS. (cited 5 July 2014). http://www.uktis.org/
41. Pole M, Einarson A, Pairaudeau N, et al. Drug labeling and risk perceptions of teratogenicity: a survey of pregnant Canadian women and their health professionals. J Clin Pharmacol 2000; 40: 573-7.